Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2018/0221337 METHODS AND COMPOSITIONS FOR TREATING METABOLIC REPROGRAMMING DISORDERS
The disclosure provides methods of treating a condition, disease, or disorder in a subject that involves metabolically reprogrammed cells whose activation,...
2018/0221336 DOSE SPARING KETOROLAC FORMULATIONS AND METHODS AND DEVICES FOR USE WITH SAME
The invention provides a unit dosage form of Ketorolac providing for a reduced dosage than typically provided to a subject in need of same, wherein said dosage...
2018/0221335 LASOFOXIFENE TREATMENT OF BREAST CANCER
The disclosure provides methods for treating estrogen receptor positive (ER.sup.+) cancer in women with an effective amount of lasofoxifene, a pharmaceutically...
2018/0221334 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF CYSTIC FIBROSIS
The present invention discloses compounds according to Formula I: ##STR00001## wherein R.sup.1 is as defined herein. The present invention relates to compounds...
2018/0221333 OPTIMIZED CANNABIS-BASED APHRODISIAC AND MOOD ENHANCER
A formulated cannabis product includes a cannabinoid mix and carrier processed by nano-emulsification. The cannabinoid mix in one embodiment includes between...
2018/0221332 Flash-Melt Cannabinoid Formulations
The present invention relates to dosage forms for the production of flash-melt cannabis resin and extract oral dosage forms
2018/0221331 PREVENTION OF ROSACEA INFLAMMATION
The disclosure demonstrates the role of mast cell stabilizers in treating rosacea. The disclosure also shows the role of mast cells, cathelicidin, serine...
2018/0221330 MODULATORS OF MITOCHONDRIAL PROTEIN IMPORT
The present invention provides compounds that modulate protein translocation in mitochondria, compositions thereof, and methods of identifying, making and...
2018/0221329 CIS- AND TRANS-SUFFRUTICOSOL D AS THERAPEUTIC AGENTS
The cis- and trans-isomers of the plant-derived compound suffruticosol D are shown to have anticancer properties. Therapeutic and prophylactic compositions...
2018/0221328 Treatment of Obesity Using Non-Daily Administration of 6-O-(4-Dimethylaminoethoxy) Cinnamoyl Fumagillol
The invention generally relates to methods of treating an overweight or obese subject, and treating overweight- or obesity-related conditions using non-daily...
2018/0221327 METHODS OF THERAPEUTIC MONITORING OF NITROGEN SCAVENGING DRUGS
The present disclosure provides methods for evaluating daily ammonia exposure based on a single fasting ammonia blood level measurement, as well as methods...
2018/0221326 METHODS OF THERAPEUTIC MONITORING OF NITROGEN SCAVENGING DRUGS
The present disclosure provides methods for evaluating daily ammonia exposure based on a single fasting ammonia blood level measurement, as well as methods...
2018/0221325 METHODS OF THERAPEUTIC MONITORING OF NITROGEN SCAVENGING DRUGS
The present disclosure provides methods for evaluating daily ammonia exposure based on a single fasting ammonia blood level measurement, as well as methods...
2018/0221324 METHODS OF THERAPEUTIC MONITORING OF NITROGEN SCAVENGING DRUGS
The present disclosure provides methods for evaluating daily ammonia exposure based on a single fasting ammonia blood level measurement, as well as methods...
2018/0221323 Treatment and Prevention of Liver Disease Associated with Parenteral Nutrition (PN)
The present invention is based on the discovery that parenteral nutrition (PN) induced liver disease, e.g. fatty liver disease, can be prevented and even...
2018/0221322 OMEGA-3 FATTY ACID ARTICLES OF MANUFACTURE, AND METHODS AND APPARATUS FOR MAKING SAME
Embodiments of the present invention are directed to methods, apparatus and articles of manufacture that feature omega-3 fatty acids co-processed with...
2018/0221321 METHODS AND PRODUCTS RELATED TO GLUTAMINASE INHIBITORS
The invention relates to methods and related compositions for enhancing cancer therapy and in particular glutaminase inhibitor therapy. The methods involve...
2018/0221320 TREATMENT AND PREVENTION OF MUSCLE LOSS USING L-ORNITHINE IN COMBINATION WITH AT LEAST ONE OF PHENYLACETATE AND...
Disclosed herein are methods of treating and preventing muscle loss using ornithine in combination with at least one of phenyl acetate and phenylbutyrate.
2018/0221319 METHODS OF TREATING SEIZURE DISORDERS AND PRADER-WILLI SYNDROME
Methods of treating a seizure disorder with (1S,3S)-3-amino-4-(difluoromethylidene)cyclopentane-1-carboxylic acid, or ...
2018/0221318 Compositions and Methods for Treating Skin Conditions Using Light and Polycarboxylic Acids
The present invention provides compositions, methods and kits for treating acne and other skin conditions influenced by P. acnes, which combine administration...
2018/0221317 COMPOSITION FOR THE TREATMENT OF SUPERFICIAL LESIONS
The invention relates to a composition for the treatment of superficial lesions, in particular skin lesions, mucous membrane lesions and/or nail lesions, an...
2018/0221316 METHODS AND MATERIALS FOR REDUCING DAMAGE TO TRANSPLANTED TISSUE
This document provides methods and materials for reducing the degree of damage to tissue transplanted into a mammal following transplantation. For example,...
2018/0221315 COMBINATION THERAPY USING ACAMPROSATE AND D-CYCLOSERINE
Described herein is a method for treating a medical condition in a patient, the method comprising: administering to a patient in need (thereof a pharmaceutical...
2018/0221314 ORAL LIQUID COMPOSITIONS OF GUANFACINE
The present invention relates to oral liquid compositions of guanfacine. The liquid compositions can be immediate release or extended release compositions. The...
2018/0221313 USE OF HYDROXYCARBAMIDE FOR PREVENTING RETINAL NONPERFUSION
The present invention relates to the use of hydroxycarbamide (HC) for reducing and/or delaying the extension of capillary nonperfusion, a cause of irreparable...
2018/0221312 CXCR-2 INHIBITORS FOR TREATING DISORDERS
N-(6-(((2R,3S)-3,4-dihydroxy butan-2-yl)oxy)-2-((4-fluoro benzyl)thio)pyrimidin-4-yl)-3-methylazetidine-1-sulfonamide (compound 4), a known chemokine...
2018/0221311 MATERIALS AND METHODS FOR CONTROLLING INFECTIONS
The subject invention provides materials methods for reducing infections in subjects. The materials methods utilize chlorhexidine, which has been found to be...
2018/0221310 METHOD OF TREATING CANCER WITH A COMBINATION OF BENZYLIDENEGUANIDINE DERIVATIVES AND CHEMOTHERAPEUTIC AGENT
The present invention relates to a composition for use in treating a glioma or ameliorating the effects of a glioma, particularly glioblastoma, wherein said...
2018/0221309 TREATMENT AND PREVENTION OF FUNGAL INFECTIONS
Various embodiments disclosed relate to treatment of fungal infections. The present invention provides a method of treating a fungal infection including...
2018/0221308 PROLONGED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING 3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYL-PROPYL)PHENOL
A pharmaceutical formulation for prolonged release of the active ingredient 3-(3-dimethylamino-1-ethyl-2-methylpropyl)phenol or a pharmaceutically acceptable...
2018/0221307 TAMPER RESISTANT DOSAGE FORM WITH BIMODAL RELEASE PROFILE MANUFACTURED BY CO-EXTRUSION
The invention relates to a monolithic pharmaceutical dosage form comprising a hot melt-extruded first segment (S.sub.1) and a second segment (S.sub.2); wherein...
2018/0221306 PHARMACEUTICAL COMPOSITIONS OF 5-HYDROXY-2-METHYLNAPHTHALENE-1,4-DIONE
Disclosed herein are pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1,4-dione. Also disclosed are methods of treating diseases and/or conditions...
2018/0221305 ANTIMICROBIALS AND METHODS OF USE THEREOF FOR WOUND HEALING
This disclosure provides generally for antimicrobial compositions and methods of use comprising an anthocyanin, an anthocyanidin or metabolites thereof....
2018/0221304 CANNABINOID-CONTAINING COMPLEX MIXTURES FOR THE TREATMENT OF MAST CELL-ASSOCIATED OR BASOPHIL-MEDIATED...
Provided herein are cannabinoid-containing complex mixtures suitable for use as active pharmaceutical ingredients. The complex mixtures are comprised of the...
2018/0221303 PERITONEAL THERAPEUTIC FLUID
Peritoneal therapeutic fluid comprising one or more of a biocompatibility enhancing agent (BCA) that is selected from the group consisting of a polyphenolic...
2018/0221302 ADJUSTING PARTICLE SIZE IN FLUOROCARBON NANOEMULSIONS
The invention provides devices and methods for adjusting particle size in nanoemulsions of fluorocarbons and perfluorocarbons (e.g., perfluoropentane and...
2018/0221301 TRANSDERMAL SYSTEMS CONTAINING MULTILAYER ADHESIVE MATRICES TO MODIFY DRUG DELIVERY
A transdermal drug-containing dosage unit comprises: a backing layer substantially impervious to the drug to be delivered transdermally; a first polymeric...
2018/0221300 Transdermal Delivery System Including an Interface Mediator
Transdermal therapeutic system for the transdermal administration of a systemically active agent comprising a self-adhesive layer structure, comprising A) a...
2018/0221299 TRANSDERMAL DELIVERY SYSTEM
The present invention provides a transdermal delivery system comprising (R)-dihydroetorphine, or a salt, hydrate or derivative thereof, wherein said system has...
2018/0221298 TRANSDERMAL DELIVERY SYSTEM
The present invention provides a transdermal patch comprising: a drug-containing layer comprising (R)-dihydroetorphine, or a salt or a hydrate thereof, and a...
2018/0221297 System and Method for Improving Adhesion of Transdermal Delivery Devices
Transdermal drug delivery devices and systems with improved adhesion are disclosed. The transdermal drug delivery devices, or patches, include an integrated...
2018/0221296 INTRASITE ADMINISTRATION AND DOSING METHODS AND PHARMACEUTICALS FOR USE THEREIN
A new method of targeted drug administration to wounds (surgical or traumatic), intrasite (IS), offers advantages in treatment efficacy and safety over...
2018/0221295 PHARMACEUTICAL COMPOSITION COMPRISING ELECTROHYDRODYNAMICALLY OBTAINED FIBRES, THE COMPOSITION HAVING IMPROVED...
The present invention relates to electrospun fibres containing: i) a first and a second hydrophilic fibre-forming polymer that is soluble in a hydrophilic...
2018/0221294 SOLID NANOPARTICLE WITH INORGANIC COATING
A nanoparticle having a solid core comprising a biologically active substance, said core being enclosed by an inorganic coating, a method for preparing the...
2018/0221293 MUCUS PENETRATING PARTICLES WITH HIGH MOLECULAR WEIGHT AND DENSE COATINGS
Mucus penetrating particles (MPPs) include one or more core polymers, one or more therapeutic, prophylactic and/or diagnostic agents; and one or more surface...
2018/0221292 Janus particles and Application Thereof
The present invention provides Janus particles and a novel vesicle. In particular, the novel vesicle comprises a plurality of the Janus particles. The Janus...
2018/0221291 Process for forming Janus particles and Application Thereof
The present invention provides a process for forming Janus particles. The novel application of the Janus particles is also disclosed in the present invention....
2018/0221290 EXTENDED RELEASE SUSPENSION COMPOSITIONS
The present invention relates to a method for preparing a stable extended release suspension composition comprising multiple coated cores of an active...
2018/0221289 PHOSPHOLIPID-CHOLESTERYL ESTER NANOFORMULATIONS AND RELATED METHODS
In one aspect, the invention provides therapeutic agent nanoparticles coated with cholesteryl esters, formulations of the nanoparticles suitable for injection,...
2018/0221288 ENTERIC CAPSULE
A capsule excellent in enteric property with the assumption that gelatin is used as a main base material of the capsule coating. An alkali-treated gelatin and...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.